OPIANT PHARMACEUTICALS, INC. 4/A SEC Filings

Filed On	Filing
13 Jul 2020	Form 4/A: Sinclair Michael, Director Disposed of 2,000 shares (Other Transaction)
06 Mar 2019	Form 4/A: Sinclair Michael, Director Holds 30,000 shares of Common Stock
03 Dec 2015	Form 4/A: Sinclair Michael, Director Granted 235,000 Options · Granted 100,000 Options · Granted 75,000 Options · 6 more

Comments